Downtrend on the daily chart: below its 50-day average · SuperTrend down since Aug 25 · below the Ichimoku cloud · RSI 27 (oversold) · MACD below its signal · 4% above its 52-week low
None of the 29 investors followed here reported a position in JATT in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a JATT trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 19, 2026 | Sidhu SomeitChief Executive Officer | Purchase at price 10.25 per share. | 300K | $3.08M |
| Apr 19, 2026 | Jatt Ventures Ii LpBeneficial Owner of more than 10% of a Class of Security | Purchase at price 10.25 per share. | 300K | $3.08M |
No analyst coverage for this instrument.
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.